These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30032042)

  • 1. Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosis.
    Adamec I; Pavlović I; Pavičić T; Ruška B; Habek M
    Mult Scler Relat Disord; 2018 Oct; 25():43-45. PubMed ID: 30032042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylprednisolone-induced hepatotoxicity in a 16-year-old girl with multiple sclerosis.
    Rotondo E; Graziosi A; Di Stefano V; Mohn AA
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis.
    Kimura H; Takeda A; Kikukawa T; Hasegawa I; Mino T; Uchida-Kobayashi S; Ohsawa M; Itoh Y
    Mult Scler Relat Disord; 2020 Jul; 42():102065. PubMed ID: 32259746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: a case report and brief review of literature.
    D'Agnolo HM; Drenth JP
    Neth J Med; 2013 May; 71(4):199-202. PubMed ID: 23723114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.
    Nociti V; Biolato M; De Fino C; Bianco A; Losavio FA; Lucchini M; Marrone G; Grieco A; Mirabella M
    Brain Behav; 2018 Jun; 8(6):e00968. PubMed ID: 29729087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute liver toxicity due to methylprednisolone: consider this diagnosis in the context of autoimmunity.
    Carrier P; Godet B; Crepin S; Magy L; Debette-Gratien M; Pillegand B; Jacques J; Sautereau D; Vidal E; Labrousse F; Gondran G; Loustaud-Ratti V
    Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):100-4. PubMed ID: 23318289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylprednisolone-induced acute liver injury in a patient treated for multiple sclerosis relapse.
    Bresteau C; Prevot S; Perlemuter G; Voican C
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29507031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity after high-dose methylprednisolone for demyelinating disease.
    Loraschi A; Banfi P; Mauri M; Sessa F; Bono G; Cosentino M
    Clin Neuropharmacol; 2010; 33(1):52-4. PubMed ID: 19935411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.
    Ferraro D; Mirante VG; Losi L; Villa E; Simone AM; Vitetta F; Federzoni L; Nichelli PF; Sola P
    Neurologist; 2015 Jun; 19(6):153-4. PubMed ID: 26075468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review.
    Zoubek ME; Pinazo-Bandera J; Ortega-Alonso A; Hernández N; Crespo J; Contreras F; Medina-Cáliz I; Sanabria-Cabrera J; Sanjuan-Jiménez R; González-Jiménez A; García-Cortés M; Lucena MI; Andrade RJ; Robles-Díaz M
    United European Gastroenterol J; 2019 Jul; 7(6):825-837. PubMed ID: 31316787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent high-dose intravenous methylprednisolone succinate pulse therapy-induced hepatopathy in a patient with multiple sclerosis.
    Furutama D; Kimura F; Shinoda K; Maeda T; Tanaka T; Ohsawa N
    Med Princ Pract; 2011; 20(3):291-3. PubMed ID: 21455003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis.
    Oliveira AT; Lopes S; Cipriano MA; Sofia C
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26199298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Steroid therapy for multiple sclerosis].
    Oishi C; Sakuta M
    Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis.
    Das D; Graham I; Rose J
    Indian J Gastroenterol; 2006; 25(6):314-6. PubMed ID: 17264438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis.
    Boz C; Terzi M; Zengin Karahan S; Sen S; Sarac Y; Emrah Mavis M
    Mult Scler; 2018 Aug; 24(9):1205-1211. PubMed ID: 28649909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent acute liver toxicity from intravenous methylprednisolone].
    Rivero Fernández M; Riesco JM; Moreira VF; Moreno A; López San Román A; Arranz G; Ruiz Del Arbol L
    Rev Esp Enferm Dig; 2008 Nov; 100(11):720-3. PubMed ID: 19159178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey.
    Dumortier J; Cottin J; Lavie C; Guillaud O; Hervieu V; Chambon-Augoyard C; Scoazec JY; Vukusic S; Vial T
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):497-501. PubMed ID: 28438569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis.
    Vasheghani-Farahani A; Sahraian MA; Darabi L; Aghsaie A; Minagar A
    J Neurol Sci; 2011 Oct; 309(1-2):75-8. PubMed ID: 21831398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis.
    Zorzon M; Zivadinov R; Locatelli L; Giuntini D; Toncic M; Bosco A; Nasuelli D; Bratina A; Tommasi MA; Rudick RA; Cazzato G
    Eur J Neurol; 2005 Jul; 12(7):550-6. PubMed ID: 15958096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.